Elizabeth Anderson
Stock Analyst at Evercore ISI Group
(3.79)
Main Sectors:
29 Stocks
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
LH Labcorp Hldgs | Maintains: Outperform | 300 305 | 276.5 | 10.31% | 7 | Oct 3, 2025 | |
MCK McKesson | Maintains: Outperform | 800 825 | 736.26 | 12.05% | 7 | Sep 24, 2025 | |
HCAT Health Catalyst | Maintains: In-Line | 3 4 | 2.95 | 35.59% | 8 | Aug 28, 2025 | |
HSIC Henry Schein | Upgrades: Outperform | 83 | 67.07 | 23.75% | 1 | Aug 26, 2025 | |
CAH Cardinal Health | Maintains: Outperform | 200 190 | 156.15 | 21.68% | 9 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: In-Line | 5 7 | 9.41 | -25.61% | 9 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 50 60 | 51.44 | 16.64% | 1 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: In-Line | 7 8 | 8.97 | -10.81% | 4 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 30 28 | 24.08 | 16.28% | 4 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 19 23 | 20.83 | 10.42% | 4 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 170 180 | 206.71 | -12.92% | 6 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: In-Line | 5 3 | 1.13 | 165.49% | 5 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 50 70 | 73.2 | -4.37% | 8 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 165 200 | 132.25 | 51.23% | 13 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: In-Line | 175 180 | 178.74 | 0.7% | 3 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 60 65 | 77.49 | -16.12% | 6 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: In-Line | 9 12 | n/a | n/a | 13 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 20 | 13.19 | 51.63% | 7 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 32 36 | 38.6 | -6.74% | 4 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 5 5 | n/a | n/a | 3 | Apr 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 12 16 | n/a | n/a | 2 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 25 39 | n/a | n/a | 2 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 185 | n/a | n/a | 9 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 7 5 | n/a | n/a | 1 | Sep 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 11 12 | n/a | n/a | 2 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: In-Line | 68 27 | 4.71 | 457.32% | 3 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 35 15 | 4.46 | 236.32% | 3 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 11 | 2.1 | 423.81% | 2 | Jan 4, 2022 |